CD123-ENG.IL15 and CD123-ENG T-cells had significant anti-AML activity compared with NT or CD19-ENG.IL15 T-cells within 10 days after T-cell infusion as judged by bioluminescence imaging (BLI, Figures 3A, B). This evidence concerns the gene CD19 and acute myeloid leukemia.